Effect of electronic laboratory reporting on the burden of lyme disease surveillance - New Jersey, 2001-2006

Morbidity and Mortality Weekly Report

Volumn 57, Issue 2, 2008, Pages 42-45

  McHugh, L A ^a   Semple, S ^a   Sorhage, F E ^a   Tan, C G ^a   Langer, A J ^b  

^a New Jersey Dept of Health and Senior Svcs

^b CDC ^*

Author keywords

[No Author keywords available]

Indexed keywords

EID: 38949156792     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Note

References (9)

1. CDC. Lyme disease - United States, 2003-2005. MMWR 2007;56:573-6.
2. CDC. Updated guidelines for evaluating public health surveillance systems: recommendations from the guidelines working group. MMWR 2001;50(No. RR-13).
3. CDC. Case definitions for infectious conditions under public health surveillance. MMWR 1997;46(No. RR-10).
4. Council of State and Territorial Epidemiologists. Position statement 07-ID-11. Revised national surveillance case definition for Lyme disease. Available at http://www.cste.org/ps/2007ps/2007psfinal/id/07-id-11.pdf.
5. Connecticut Department of Public Health. Lyme disease - Connecticut, 2005. Connecticut Epidemiologist 2006;26:13-4. Available at http://www.ct.gov/ dph/lib/dph/infectious_diseases/pdf_forms_/vol26no4.pdf.
6. CDC. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR 1995;44:590-1.
7. Dressler F, Whalen JA, Reinhardt BN, Steere AC. Western blotting in the serodiagnosis of Lyme disease. J Infect Dis 1993;167:392-400.
8. Engstrom SM, Shoop E, Johnson RC. Immunoblot interpretation criteria for serodiagnosis of early Lyme disease. J Clin Microbiol 1995;33:419-27.
9. CDC. Caution regarding testing for Lyme disease. MMWR 2005;54:125.